Type
Waters, Laing, Rees. Proven primary dapsone resistance in leprosy--a case report. Leprosy review [Internet]. 1978;49(2):127-30. Available from: http://leprev.ilsl.br/pdfs/1978/v49n2/pdf/v49n2a04.pdf
Type
Colston, Ellard, Gammon. Drugs for combined therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general review. Leprosy review [Internet]. 1978;49(2):115-26. Available from: http://leprev.ilsl.br/pdfs/1978/v49n2/pdf/v49n2a03.pdf
Type
Braun-Falco, Bilek. [Picture report. Chondrodermatitis nodularis chronica helicis, gout tophi, lymphadenosis benigna cutis, lepra lepromatosa, sarcoidosis, lupus vulgaris, ulcerating specific skin infiltrates in lymphatic leukemia, spinocellular carcinoma]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1978;29(6):345-6.
Type
Soderstrom, Krull. Erythema nodosum. A review. Cutis. 1978;21(6):806-10.
Type
Goihman-Yahr, Convit, Rodríguez-Ochoa, Aranzazu, Villalba-Pimentel, Ocanto, et al. Significance of neutrophil activation in reactional lepromatous leprosy: effects of thalidomide in vivo and in vitro. Activation in adjuvant disease. International archives of allergy and applied immunology. 1978;57(4):317-32.
Type
Freerksen, Rosenfeld, Bonnici, Depasquale, Kriiger-Thiemer. Combined therapy in leprosy. Background and findings. Chemotherapy. 1978;24(3):187-201.
Type
Hogeweg, Leiker DL. A survey on eye involvement among leprosy patients in The Netherlands. Documenta ophthalmologica. Advances in ophthalmology. 1983;56(1-2):69-76.
Type
Lerche, Enk, Jensen, Black. [Leprosy--even in Denmark. Review and report of 4 cases]. Ugeskrift for laeger. 1983;145(50):3885-8.
Type
DE MESQUITA. [Health education in Hansen's disease]. Hansenologia internationalis. 1983;8(2):148-9.
Type
Teixeira, Manhães, Almeida, Barroso, Silva. [Clinical and epidemiological evaluation of Hansen's disease August 1937 to December 1980 in the Sanitary Dermatology Service of the Health Center of Campos, RJ]. Hansenologia internationalis. 1983;8(2):133-9.